ArticleJournal for immunotherapy of cancer2019

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.

Madelyn Espinosa-Cotton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.